The Dental Practice Market in 2026: What Practices for Sale Actually Collect

Two general practices collect $900,000 a year. One sells for $720,000. The other sells for $1,188,000. Nothing separates them but a margin line neither owner looked at closely until the year they decided to quit.

Here is the claim, and plenty of brokers will argue with it: the 60% to 80% of collections rule of thumb that prices most single-location dental practices is not a shortcut to a fair number. It's a discount, and it's a bet that your practice runs at roughly a 12% to 14% operating margin. Run better than that and the rule of thumb quietly moves several hundred thousand dollars from your retirement account to your buyer's balance sheet. Run worse and it's the most generous offer you will ever receive, and you should sign it before anyone builds a real earnings statement.

The reason this matters more in 2026 than it did in 2016 is that the underlying business got harder while the pricing conventions stayed the same. Over the past five years, practice revenues rose 1.4% while expenses rose 4.9%, according to the ADA Health Policy Institute. Average net income for a GP owner landed at $215,320 in 2025, which sounds fine until you read the rest of the sentence: adjusted for inflation, that number was flat on the year and has been declining for fifteen years. The market is pricing a shrinking coupon at a fixed multiple, and most owners only find out which side of the average they are on during due diligence.

The 15.2% Line That Decides Your Price

Every credible valuation of a dental practice runs through one number: adjusted EBITDA, meaning what the business earns after you pay someone at market rate to do the dentistry you currently do for free-ish. The five-year industry-average EBITDA margin is 15.2% of revenue, and staff compensation averaged 38.9% of revenue in 2025, per VERTESS. Those two figures, taken together, describe the entire negotiation.

Work it on a $900,000 practice. Staff compensation at the industry average costs $350,100. If that practice also hits the average margin, adjusted EBITDA is $136,800. Which means everything else, the normalized doctor cost, lab, supplies, rent, insurance, software, marketing, consumes $413,100.

The normalized doctor cost is where owners get surprised. Buyers do not capitalize your take-home. They strip your compensation out, insert a market provider cost, and capitalize what's left. The government benchmark they reach for is the median annual wage for dentists, $176,110 as of May 2025 across 161,400 jobs, published by the Bureau of Labor Statistics. Whatever you actually pay yourself, the deal math assumes a replacement who costs something in that neighborhood, scaled to production. Your W-2 is an accounting choice. The replacement cost is not.

Where the Rule of Thumb Costs $468,000

Private dentist buyers price practices under $1M in collections at 60% to 80% of trailing collections, and EBITDA multiples in that same size band run roughly 5x to 7x, according to Dental Transitions. Both conventions are real. They just disagree, and the disagreement is worth more than most owners' last three years of profit.

Take the same $900,000 practice three ways.

Average practice, 15.2% margin. Adjusted EBITDA of $136,800 at 5x is $684,000, and at 7x it's $957,600. The collections rule of thumb says $540,000 to $720,000. The two methods overlap only at the very bottom of the earnings range. Even a perfectly average practice is priced under its own earnings math by the percentage rule.

Weak practice, 10% margin. Adjusted EBITDA of $90,000 at 6x is $540,000, while 70% of collections is $630,000. The rule of thumb pays this owner $90,000 more than the business earns the right to. Take it. Take it the same afternoon.

Strong practice, 22% margin. Adjusted EBITDA of $198,000 at 6x is $1,188,000, against a rule-of-thumb ceiling of $720,000 at the top of the collections band. That's $468,000 left on the table by an owner who ran a tighter business than everyone around them.

You can solve for the indifference point. At a 6x multiple, 70% of collections implies a margin of 11.7%. At 5x, it implies 14%. So the collections rule is a wager that you run at roughly 12% to 14%, below the 15.2% five-year average. Our view: if your trailing-twelve margin clears 15%, refuse to negotiate on a percentage of collections at all. Make the buyer price the earnings, or find a buyer who will.

What Most Owners Get Wrong About Their $215,320

The specific mistake, and it is made most often by solo GPs inside 24 months of retirement, is treating the last two years before a sale as a production sprint. They add a hygiene day, take on two more PPO plans, hire another assistant, and push collections from $820,000 to $900,000, because the rule of thumb told them price is a function of the top line. Then they discover that the incremental $80,000 arrived carrying 38.9% staff cost, a discounted fee schedule, and more chair time, and it moved adjusted EBITDA by almost nothing. They bought $80,000 of revenue at a price of roughly zero enterprise value, and they worked harder for it.

The second version of the mistake is reading the $215,320 average GP income and assuming a buyer will pay a multiple on all of it. They won't. Strip out a market provider cost near the $176,110 BLS median and the pure ownership premium at dead-center average is $39,210. Capitalize that at 5x and you get $196,050. That is not a prediction of what an average practice sells for, because most owners' books contain real add-backs and most practices are not exactly average. It is an illustration of the distance between the income you live on and the earnings a buyer will actually pay for. Those are two different numbers, and only one of them is for sale.

Owners who understand this stop optimizing for production three years out and start optimizing for margin. Every dollar of recurring cost you remove is worth five to seven dollars at close. Every dollar of low-margin revenue you add is worth close to nothing.

Why Your Neighbor's 11x Isn't Available to You

You've heard the double-digit multiples. They're real and they are not yours. Multiples scale from roughly 5x to 7x for practices under $1M in adjusted EBITDA up to 11x and beyond above $5M in adjusted EBITDA, per Dental Transitions. At the industry-average 15.2% margin, $5M of adjusted EBITDA requires about $32.9M in collections. That is a group, not an office. The 11x is a price paid for a portfolio with regional density and a management layer, and the buyer paying it is usually selling that same portfolio to a larger buyer at a higher number. You are a component in that trade, priced at component multiples.

Which brings up structure. DSO deals typically come as 60% to 80% cash at close with 20% to 40% in rollover equity. That rollover is where the headline multiple gets manufactured. A 7x headline on a deal that's 30% rollover is a 4.9x cash deal plus a lottery ticket in someone else's capital structure. We'd underwrite the rollover at zero. If the deal still beats your alternatives with the equity valued at nothing, it's a good deal and the rollover is upside. If it only works when the rollover pays out at the sponsor's projected exit, we wouldn't take it.

Expenses Grew 4.9% While Revenue Grew 1.4%

Here is the part that should change how you think about timing. The ADA's five-year picture, 1.4% revenue growth against 4.9% expense growth, is not a forecast, it's the recent past, and it compounds directly into your sale price.

Run it on the average $900,000 practice. Revenue grows 1.4% and adds $12,600. The cost base of $763,200 grows 4.9% and adds $37,397. Net effect on adjusted EBITDA: down $24,797 in a single year. At a 6x multiple, that one year of drift removes $148,782 from your sale price.

A year of doing nothing about margin doesn't cost you $24,797 of profit. It costs you $148,782 of the number on the closing statement. That is the sentence to text your spouse.

The strategic conclusion is uncomfortable for anyone who planned to coast to the finish. In a market where expenses outrun revenue by 3.5 points a year, the practice you sell in 2029 is a materially worse asset than the one you could sell in 2026 unless you actively defend the margin in between. We'd rather see an owner spend the next 18 months cutting $40,000 of recurring cost than adding $100,000 of discounted production. The cut is worth $240,000 at 6x. The production, after staff cost and PPO write-downs, may be worth nothing.

Three Numbers to Pull Before Friday

Pull your trailing-twelve collections, your total staff compensation including taxes and benefits, and your owner compensation in all its forms, salary, distributions, auto, retirement match, personal items running through the practice. Calculate staff comp as a percent of collections and compare it to 38.9%. Then rebuild your profit line with your own pay replaced by a market provider cost and divide the result by collections to get your real margin. If that number is above 15.2%, you are worth more than any percentage of collections a buyer will offer you, and you should not sell on that basis.

If you want to see where you land before a broker tells you, run your own numbers through our free practice valuation calculator. It does exactly the work above: normalizes your compensation, computes adjusted EBITDA, and shows you what the 5x to 7x band and the 60% to 80% collections rule each produce for your practice, so you know which method to insist on. We're tracking whether the 2026 buyer pool starts underwriting margin over collections as expense growth keeps outpacing revenue. If percentage-of-collections offers begin clustering at the top of the 80% range for high-margin practices, we'll revisit the call. Until then, the rule of thumb is a tax on well-run offices, and the fix is knowing your own margin before anyone else does.